Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational 'ecstasy' users.
about
Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humansIllicit stimulant use in humans is associated with a long-term increase in tremorMDMA effects consistent across laboratories.Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification.The mixture of "ecstasy" and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations.Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences.Deaths from exposure to paramethoxymethamphetamine in Alberta and British Columbia, Canada: a case seriesNanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophagesBehavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboonsEffects of MDMA on body temperature in humansCarvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans: Lost in translation.Pharmacology should be at the centre of all preclinical and clinical studies on new psychoactive substances (recreational drugs).The risky cocktail: what combination effects can we expect between ecstasy and other amphetamines?Recreational drug use and binge drinking: stimulant but not cannabis intoxication is associated with excessive alcohol consumption.Multiple MDMA (Ecstasy) overdoses at a rave event: a case series.Single oral doses of (±) 3,4-methylenedioxymethamphetamine ('Ecstasy') produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations.Is online information on ecstasy tablet content safe?Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart.
P2860
Q26859367-7EF76303-3465-4765-A9E3-255E81960E27Q28484412-BD35962C-9F48-46E0-86BB-D01178F189D5Q34167689-680E600B-FD51-4716-AE48-1DC3C4E073E9Q34270487-976A0FF2-0CD7-491B-BF19-C9515F5BA3D4Q34375859-A044717B-9263-4A66-9AD2-C3AA663023F7Q35077922-4F8A583A-6BEE-4DB5-ACAC-9337184300BEQ35241213-382E9AF5-08F0-4102-95DF-C7BB6ED39D40Q36166289-38336C23-FBDE-4BC4-97EA-A347ECB6FBF5Q36852604-243C8A0B-B65D-466C-9FAC-744DA082AB8EQ37226598-40D69495-56B8-4C39-BA5B-1AAE938FB1DEQ37337904-8A15857B-A382-4022-BC98-2D6DB162041BQ39221467-9C27E8FA-3885-4928-BE7E-FC1983C66230Q39273495-915E0C9C-A792-429E-94B2-AC0327198FEEQ43442956-EAE82623-51C8-4CD4-8144-C790392F688BQ44321580-F3406881-BA81-47B0-9DC5-003FFDDE73A2Q45053309-5C5102B1-6C50-4139-B398-0DD1605BD5D3Q47961571-2BB27036-839D-4609-BFDE-81B57B6F8C83Q50549548-276EC05F-4452-41A2-A470-0F28D0757935
P2860
Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational 'ecstasy' users.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Pill content, dose and resulti ...... recreational 'ecstasy' users.
@en
Pill content, dose and resulti ...... recreational 'ecstasy' users.
@nl
type
label
Pill content, dose and resulti ...... recreational 'ecstasy' users.
@en
Pill content, dose and resulti ...... recreational 'ecstasy' users.
@nl
prefLabel
Pill content, dose and resulti ...... recreational 'ecstasy' users.
@en
Pill content, dose and resulti ...... recreational 'ecstasy' users.
@nl
P2093
P2860
P1433
P1476
Pill content, dose and resulti ...... recreational 'ecstasy' users.
@en
P2093
Kate M Morefield
Michael Keane
Peter Felgate
Rodney J Irvine
P2860
P304
P356
10.1111/J.1360-0443.2011.03399.X
P407
P577
2011-05-03T00:00:00Z